Global Cure AIDS Clinical Trials

Global Cure AIDS Clinical Trials and how the National Institutes of Health (NIH) is expanding its efforts to find a Cure for HIV

Jonas Salk discovered a cure for polio on April 12, 1955. His last years were spent searching for an HIV vaccine.

As it relates to Global Cure AIDS Clinical Trials and through it’s efforts and research in the U.S. and around the world the NIH seeks to:
  • Identify HIV reservoirs throughout the body
  • Determine the effects of antiretroviral therapy, chemotherapy, and other strategies on the HIV reservoir
  • Develop assays and model systems, including a nonhuman primate model, to quantify and study HIV latency
  • Characterize viral reservoirs that cause rebounding of viral levels when antiretroviral therapy is stopped
  • Determine the role of HIV integration on virus elimination strategies
  • Determine the role of HIV in hematopoietic progenitor cells regarding cure strategies
  • Investigate strategies that lead to purging of the latent reservoir and a cure for HIV/AIDS

 

 


SEARCH NOWGlobal Cure AIDS Clinical Trials listed by United States and Countries

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about a Global AIDS Cure Clinical Trial, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies. NOTE: If you want to be notified of a Cure for AIDS Study in your area, please fill out the Cure Report Alert and we will send you a private email about study recruitment, news and updates.

Each Global Cure AIDS Clinical Trial has a designation of either…

AIDS clinical trials

Recruiting

      Not yet Recruiting (Come Back or Contact)

      Ongoing but Not Recruiting


 

United States Global Cure AIDS Clinical Trials

 (Click on a State below to find Global Cure AIDS Clinical Trials in that area).

Alabama

Alabama

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Alabama Therapeutics CRS (5801)
Birmingham, Alabama, United States, 35294
Contact: Karen Savage, BSN 205-975-7925 kgsavage@uab.edu Principal Investigator: Victoria Johnson, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Alabama CRS
Birmingham, Alabama, United States, 35294
Contact: Karen Savage, R.N., B.S.N. 205-975-7925 kgsavage@uab.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Alabama CRS
Birmingham, Alabama, United States, 35294
Contact: Karen Savage, R.N., B.S.N. 205-975-7925 kgsavage@uab.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
The University of Alabama at Birmingham Alabama Vaccine Research Clinic
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators:
GeoVax, Inc.
AIDS Research Consortium of Atlanta
University of Alabama at Birmingham
AIDS Research Alliance

California

California

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
San Francisco General Hospital
San Francisco, California, United States, 94110
Contact: Hiroyu Hatano, MD 415-476-4082 ext 122 hhatano@php.ucsf.edu Principal Investigator: Hiroyu Hatano, MD
Sponsors and Collaborators:
University of California, San Francisco
amfAR (The Foundation for AIDS Research)

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
UCLA CARE Center CRS (601)
Los Angeles, California, United States, 90035
Contact: Maricela Gonzalez 310-557-3798 mmgonzalez@mednet.ucla.edu Principal Investigator: Judith S. Currier, MD, MSc
UCSD, Avrc Crs (701)
San Diego, California, United States, 92103
Contact: Jill Kunkel 619-543-3094 jkunkel@ucsd.edu Principal Investigator: Constance A. Benson, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
UCLA Care Center
Los Angeles, California, United States, 90035
Contact: Maricela Gonzalez 310-557-3729 mmgonzalez@mednet.ucla.edu Principal Investigator: Ronald Mitsuyasu, MD
Quest Clinical Research
San Francisco, California, United States, 94115
Contact: Grace Gonzaga, LPN 415-353-0212 grace@questclinical.com Principal Investigator: Jacob Lalezari, MD
Orange Coast Medical Group (Please note withdrawn)
Newport Beach, California, United States, 92663
Sponsors and Collaborators:
Sangamo Biosciences

global AIDS cure clinical trials

Recruiting
Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
UCLA CARE Center
Los Angeles, California, United States, 90035
Contact: Maricela Gonzalez 310-557-3729 mmgonzalez@mednet.ucla.edu
Principal Investigator: Ronald Mitsuyasu, M.D.
Quest Clinical Research
San Francisco, California, United States, 94115
Contact: Grace Gonzaga 415-353-0212 grace@questclinical.com
Principal Investigator: Jacob Lalezari, M.D.
Sponsors and Collaborators:
Calimmune, Inc.

global AIDS cure clinical trials

Recruiting
Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
City of Hope Medical Center
Duarte, California, United States, 91010
Contact: Amrita Y. Krishnan 626-256-4673 AKrishnan@coh.org
Principal Investigator: Amrita Y. Krishnan
Sponsors and Collaborators:
City of Hope Medical Center
National Cancer Institute (NCI)

global AIDS cure clinical trials

Recruiting
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
San Francisco General Hospital
San Francisco, California, United States, 94110
Contact: Marian Kerbleski, RN 415-476-4082 ext 144 kerbleskim@php.ucsf.edu
Contact: Rebecca Hoh, MS, RD 415-476-4082 ext 139 rhoh@php.ucsf.edu
Principal Investigator: Steven Deeks, MD
Sponsors and Collaborators:
University of California, San Francisco
Monash University
amfAR (The Foundation for AIDS Research)
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
City of Hope
Duarte, California, United States, 91010
Contact: John Zaia 626-256-4673
Principal Investigator: John Zaia
Sponsors and Collaborators:
Fred Hutchinson Cancer Research Center
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)

global AIDS cure clinical trials

Recruiting
The Use of Leukapheresis to Support HIV Pathogenesis Studies
San Francisco General Hospital
San Francisco, California, United States, 94110
Contact: Hiroyu Hatano, MD 415-476-4082 ext 122 hhatano@php.ucsf.edu
Contact: Kara Harvill, BA 415-476-4082 ext 341 harvillk@php.ucsf.edu
Principal Investigator: Hiroyu Hatano, MD
Sponsors and Collaborators:
University of California, San Francisco

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
UCLA CARE Center CRS
Los Angeles, California, United States, 90035
Contact: Arezou S. Akha 310-557-3798 asadighi@mednet.ucla.edu
UCSF HIV/AIDS Crs
San Francisco, California, United States, 94110
Contact: Jay Dwyer 415-476-4082 ext 353 jdwyer@php.ucsf.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
UCSF HIV/AIDS Crs
San Francisco, California, United States, 94110
Contact: Jay Dwyer 415-476-4082 ext 353 jdwyer@php.ucsf.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
City of Hope National Medical Center
Duarte, California, United States, 91010
University of California Los Angeles
Los Angeles, California, United States, 90035
Contact: Mary Horowitz, MD, MS marymh@mcw.edu
Contact: Ellen Parker eparker@emmes.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
UCLA Center for AIDS Research and Education
Los Angeles, California, United States, 90035
Orange Coast Medical Group
Newport Beach, California, United States, 92663
Quest Clinical Research
San Francisco, California, United States, 94115
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma
City of Hope Medical Center
Duarte, California, United States, 91010-3000
Sponsors and Collaborators:
City of Hope Medical Center
National Cancer Institute (NCI)

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
UC Davis Research Office at CARES
Sacramento, California, United States, 95811
Sponsors and Collaborators:
Argos Therapeutics

Ongoing but Not Recruiting
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
AIDS Research Alliance
Los Angeles, California, United States, 90015
Sponsors and Collaborators:
GeoVax, Inc.
AIDS Research Consortium of Atlanta
University of Alabama at Birmingham
AIDS Research Alliance

Colorado

Colorado

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
University of Colorado Hospital CRS (6101)
Aurora, Colorado, United States, 80045
Contact: Mary G Ray, RN, MSN 303-724-0712 graham.ray@uchsc.edu Principal Investigator: Thomas B Campbell, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
University of Colorado Hospital CRS
Aurora, Colorado, United States, 80045
Contact: Mary Graham Ray, R.N., M.S.N. 303-724-0712 graham.ray@ucdenver.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting(Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
University of Colorado Hospital CRS
Aurora, Colorado, United States, 80045
Contact: Mary Graham Ray, R.N., M.S.N. 303-724-0712 graham.ray@ucdenver.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Connecticut

Connecticut

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Circle CARE Center, LLC
Norwalk, Connecticut, United States, 06850
Contact: Greg Ulrich, RN 203-852-9525 gulrich@whcccc.org
Principal Investigator: Gary Blick, MD
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Circle CARE Center, LLC
Norwalk, Connecticut, United States, 06851
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

District of Columbia (Washington, DC)

District of Columbia (Washington, DC)

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Georgetown University CRS (GU CRS) (1008)
Washington, District of Columbia, United States, 20007
Contact: Abimael Lopez 202-687-7387 al374@georgetown.edu Principal Investigator: Princy N. Kumar, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Walter Reed Army Medical Center
Washington, District of Columbia, United States, 20307
Sponsors and Collaborators:
University of Pennsylvania

Florida

Florida

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Orlando Immunology Center
Orlando, Florida, United States, 32803
Contact: Jeffrey Garrett, ARNP 407-647-3960 ext 2151 jgarrett@oicorlando.com
Principal Investigator: Edwin DeJesus, MD
Sponsors and Collaborators:
Sangamo Biosciences

global AIDS cure clinical trials

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Florida College of Medicine
Gainesville, Florida, United States, 32610-0277
Contact: John R Wingard, MD 352-273-7760 wingajr@medicine.ufl.edu
H. Lee Moffitt Cancer Center
Tampa, Florida, United States, 33624
Contact: Ernesto Ayala, MD 813-745-1554 ernesto.ayala@moffitt.org
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

global AIDS cure clinical trials

Recruiting
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (GCHT01)
University of Miami School of Medicine, AIDS Clinical Research unit
Miami, Florida, United States, 33136
Contact: Lillian Colon, RN,BSN 305-243-3838 lcolon2@med.miami.edu
Principal Investigator: Margaret A. Fischl, MD
Sponsors and Collaborators:
GeneCure Biotechnologies

global AIDS cure clinical trials

Recruiting
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
University of Florida Center for HIV/AIDS Research, Education, and Service
Jacksonville, Florida, United States, 32209
Contact: Anne Coletti, MS 919-544-7040 ext 11238 acoletti@fhi360.org
Principal Investigator: Mobeen Rathore, MD
Sponsors and Collaborators:
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Not yet Recruiting (Come Back or Contact)
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection (Goldrake)
University of Miami – AIDS Clinical Research Unit
Miami, Florida, United States, 33136
Contact: Margaret Fischl, MD 305-243-3847 mfschl@med.miami.edu Principal Investigator: Margaret Fischl, MD
Sub-Investigator: Hector Bolivar, MD
Sponsors and Collaborators:
Vaccine and Gene Therapy Institute, Florida
University of Miami

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Orlando Immunology Center
Orlando, Florida, United States, 32803
Contact: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Georgia

Georgia

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
The Ponce de Leon Ctr. CRS (5802)
Atlanta, Georgia, United States, 30308
Contact: Ericka Patrick 404-616-6313 erpatri@emory.edu Principal Investigator: Carlos del Rio, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
AIDS Research Consortium of Atlanta
Atlanta, Georgia, United States, 30312
Sponsors and Collaborators:
GeoVax, Inc.
AIDS Research Consortium of Atlanta
University of Alabama at Birmingham
AIDS Research Alliance

Illinois

Illinois

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Northwestern University CRS (2701)
Chicago, Illinois, United States, 60611
Contact: Baiba Berzins, MPH 312-695-5012 baiba@northwestern.edu Principal Investigator: Babafemi Taiwo, MBBS, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Maryland

Maryland

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected…
National Institutes of Health Clinical Center
9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Contact: For additional information, please contact VRC Clinic 301-451-8715 vaccines@nih.gov Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
IHV Baltimore Treatment CRS (4651)
Baltimore, Maryland, United States, 21201
Contact: Gregory Brogden, BS 410-706-1660 gbrogden@ihv.umaryland.edu Principal Investigator: Charles Davis, MD
Beth Israel Deaconess Medical Center ACTG CRS (103)
Boston, Maryland, United States, 02215
Contact: Andrea Kershaw, ANP 617-632-7627 akersha1@bidmc.harvard.edu Principal Investigator: Mary Albrecht, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Therapeutic Vaccine for HIV
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov
Contact: Kathleen R Gittens (301) 496-9320 gittenskr@mail.nih.gov
Contact: Michael C Sneller, M.D. (301) 496-0491 msneller@niaid.nih.gov
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
Profectus Biosciences, Inc.

global AIDS cure clinical trials

Recruiting
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
National Institutes of Health Clinical Center
9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov
Contact: Gabbie M Diaz, R.N. (301) 435-8019 diazgm@mail.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting

Rifaximin for Chronic Immune Activation in People With HIV
Walter Reed National Medical Center
Bethesda, Maryland, United States, 20301
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: Catherine A Seamon, R.N. (301) 451-6313 cseamon@cc.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Johns Hopkins Medical Institutions
Baltimore, Maryland, United States, 21231
Contact: Richard Ambinder, MD 410-955-8839 rambind1@jhmi.edu
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Massachusetts

Massachusetts

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
BMC ACTG Crs (104)
Boston, Massachusetts, United States, 02118
Contact: Betsy Adams, RN 617-414-7082 betsy.adams@bmc.org Principal Investigator: Paul Skolnik, MD
Brigham and Women’s Hosp. ACTG CRS (107)
Boston, Massachusetts, United States, 02115
Contact: Jon Gothing, RN 617-732-5635 jgothing@partners.org Principal Investigator: Paul E. Sax, MD
Massachusetts General Hospital ACTG CRS (101)
Boston, Massachusetts, United States, 02114
Contact: Teri Flynn, RN, ANP, MSN 617-724-0072 tflynn@partners.org Principal Investigator: Rajesh Gandhi, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, United States, 02114
Contact: Theresa Flynn, R.N., M.S.N., A.N.P. 617-724-0072 tflynn@partners.org
Brigham and Women’s Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS Not yet recruiting
Boston, Massachusetts, United States, 02115
Contact: Cheryl E. Keenan 617-732-5635 ckeenan2@partners.org
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, United States, 02114
Contact: Theresa Flynn, R.N., M.S.N., A.N.P., B.S.N. 617-724-0072 tflynn@partners.org Brigham and Women’s Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
Boston, Massachusetts, United States, 02115
Contact: Cheryl E. Keenan, R.N. 617-732-5635 ckeenan2@partners.org
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects (PARC002)
Infectious Disease Unit; Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators:
Massachusetts General Hospital

Minnesota

Minnesota

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Tissue Drug Levels of HIV Medications
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Contact: Ann Thorkelson, RN 612-625-7472 segu0017@umn.edu
Principal Investigator: Timothy W. Schacker, M.D.
Sponsors and Collaborators:
University of Minnesota – Clinical and Translational Science Institute
National Institute of Allergy and Infectious Diseases (NIAID)

Missouri

Missouri

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Washington University CRS (2101)
St. Louis, Missouri, United States, 63110
Contact: Michael Klebert, RNC, PhD, ANP 1-314-747-1098 mklebert@im.wustl.edu Principal Investigator: Edgar T. Overton, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Central West Clinical Research, Inc.
St Louis, Missouri, United States, 63108
Contact: Mark Pinson 314-652-0100 ext 832 mark.cwhealth@gmail.com
Principal Investigator: David A Parks, MD
Sponsors and Collaborators:
Sangamo Biosciences

global AIDS cure clinical trials

Recruiting
IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
Washington University School of Medicine
St Louis, Missouri, United States
Contact: Anne Coletti, MS , 919-544-7040 ext 11238, acoletti@fhi360.org
Sponsors and Collaborators:
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Washington University Therapeutics (WT) CRS
St. Louis, Missouri, United States, 63110-1010
Contact: Michael K. Klebert, R.N.,C., Ph.D., A.N.P., BCP 314-747-1098 mklebert@dom.wustl.edu Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Central West Clinical Research, Inc.
St Louis, Missouri, United States, 63108
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

New Jersey

New Jersey

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Contact: Scott Rowley, MD 201-996-5828 srowley@humed.com
Contact: Melissa Baker, MD mbaker@humed.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

New Mexico

New Mexico

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Southwest CARE Center
Santa Fe, New Mexico, United States, 87505
Contact: Jason Martinez 505-216-0318 jmartinez@southwestcare.org
Principal Investigator: Trevor Hawkins, MD
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Southwest CARE Center
Santa Fe, New Mexico, United States, 87505
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

New York

New York

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
The Rockefeller University
New York, New York, United States, 10065
Contact: Lauren Corregano 800-782-2737 rucares@rockefeller.edu Principal Investigator: Marina Caskey, MD
Sponsors and Collaborators:
Rockefeller University

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Bronx-Lebanon Hosp. Ctr. CRS (31469)
Bronx, New York, United States, 10457
Contact: Megan A Tuohy, MPH 718-901-6346 mtuohy@bronxleb.org Principal Investigator: Edward Telzak, MD
HIV Prevention & Treatment CRS (30329)
New York, New York, United States, 10032
Contact: Steven Chang 212-305-1570 sc1286@columbia.edu Principal Investigator: Scott M. Hammer, MD
Univ. of Rochester ACTG CRS (1101)
Rochester, New York, United States, 14642
Contact: Carol Greisberger, RN, BS 585-275-2740 carol_greisberger@urmc.rochester.edu Principal Investigator: Amneris Luque, MD
AIDS Community Health Ctr. ACTG CRS (1108)
Rochester, New York, United States, 14604
Contact: Carol Greisberger, RN, CCRC 585-275-2740 Carol_Greisberger@urmc.rochester.edu Principal Investigator: Roberto Corales, DO
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Ricky K Hsu, MD, PC
New York, New York, United States, 10011
Contact: Monique Carasso, NP 212-627-7560 mjcarasso@verizon.net
Principal Investigator: Ricky K Hsu, MD, PC
Sponsors and Collaborators:
Sangamo Biosciences

global AIDS cure clinical trials

Recruiting
Poly-ICLC in Treated HIV Infection
The Rockefeller University Hospital
New York, New York, United States, 10065
Contact: Elizabeth A Miller, MD 212-824-9246 elizabeth.a.miller@mssm.edu
Principal Investigator: Elizabeth A Miller, MD
Sponsors and Collaborators:
Bhardwaj, Nina, M.D.
The Campbell Foundation
Oncovir, Inc.

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
University of Rochester Adult HIV Therapeutic Strategies Network CRS
Rochester, New York, United States, 14642
Contact: Emily L. Cosimano, B.S.N. 585-276-5903 Emily_Cosimano@urmc.rochester.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University Medical Center
New York, New York, United States, 10032
Contact: Jean Sosna, RN 212-305-2050
Principal Investigator: Diane George, MD
Sponsors and Collaborators:
Diane George, MD

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10174
Contact: Ariel Noya, MD noya@mskcc.org
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Ricky K Hsu, MD, PC
New York, New York, United States, 10011
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Jacobi & North Central Bronx Hospitals
Bronx, New York, United States, 10461
Sponsors and Collaborators:
Argos Therapeutics

North Carolina

North Carolina

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
UNC AIDS Crs (3201)
Chapel Hill, North Carolina, United States, 27516
Contact: Cheryl Marcus, RN, BSN 919-843-8761 cjm@med.unc.edu Principal Investigator: David Wohl, MD
Moses H. Cone Memorial Hospital CRS (3203)
Greensboro, North Carolina, United States, 27401
Contact: Kim Epperson, RN 336-832-7888 kim.epperson@mosecone.com Principal Investigator: Timothy Lane
Regional Center for Infectious Disease, Wendover Medical Center CRS (3203)
Greensboro, North Carolina, United States, 27401
Contact: Kim Epperson, R.N., BSN., CCRC (336) 832-3262
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Chapel Hill CRS
Chapel Hill, North Carolina, United States, 27599
Contact: Susan Pedersen 919-966-6713 spederse@med.unc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27514
Contact: JoAnn Kuruc, MSN, RN 919-966-8533 joann_kuruc@med.unc.edu
Sponsors and Collaborators:
University of North Carolina, Chapel Hill
National Institutes of Health (NIH)
Merck Sharp & Dohme Corp.
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
Contact: JoAnn Kuruc, RN, MSN (919) 966-8533 joann_kuruc@med.unc.edu
Contact: Emily Barrows, RN 919-966-7747 emily_barrows@med.unc.edu
Sponsors and Collaborators:
Cynthia L Gay, MD
Argos Therapeutics
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Chapel Hill CRS
Chapel Hill, North Carolina, United States, 27599
Contact: Susan Pedersen 919-966-6713 spederse@med.unc.edu Greensboro CRS
Greensboro, North Carolina, United States, 27401
Contact: Kim Epperson, R.N., B.S.N., CRC 336-832-3262 kim.epperson@conehealth.com
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
AIDS Clinical Trials Unit
Chapel Hill, North Carolina, United States, 27514
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators:
Argos Therapeutics

Ohio

Ohio

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
University of Cincinnati CRS (2401)
Cincinnati, Ohio, United States, 45267
Contact: Tammy Mansfield, RN, ACRN 513-584-6040 mansfitl@ucmail.uc.edu Principal Investigator: Judith Feinberg, MD
Case CRS (2501)
Cleveland, Ohio, United States, 44106
Contact: Jane Baum, RN 216-844-2546 baum.jane@clevelandactu.org Principal Investigator: Michael M. Lederman, MD
Metro Health CRS (2503)
Cleveland, Ohio, United States, 44109
Contact: Julie Ziegler 216-778-7847 jziegler@metrohealth.org Principal Investigator: Robert C. Kalayjian, MD
The Ohio State Univ. AIDS CRS (2301)
Columbus, Ohio, United States, 43210
Contact: Todd Lusch, BA 614-293-8112 todd.lusch@osumc.edu Principal Investigator: Susan Koletar, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Case CRS
Cleveland, Ohio, United States, 44106
Contact: Jane Baum, R.N. 216-844-2546 jb@clevelandactu.org
Ohio State University CRS
Columbus, Ohio, United States, 43210
Contact: Kathy Watson, B.S.N. 614-293-5856 kathy.watson@osumc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Cincinnati CRS
Cincinnati, Ohio, United States, 45219
Contact: Tammy Miller, R.N., A.C.R.N. 513-584-8373 tammy.miller@uc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Pennsylvania

Pennsylvania

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Hosp. of the Univ. of Pennsylvania CRS (6201)
Philadelphia, Pennsylvania, United States, 19104
Contact: Joseph Quinn, RN 215-349-8091 joseph.quinn@uphs.upenn.edu Principal Investigator: Pablo Tebas, MD
Pitt CRS (1001)
Pittsburgh, Pennsylvania, United States, 15213
Contact: Christine A. Tripoli, BSN, RN 412-647-0771 tripolica@upmc.edu Principal Investigator: Sharon A. Riddler, MD, MPH
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, United States, 19104
Contact: Joseph Quinn, R.N. 215-349-8093 joseph.quinn@uphs.upenn.edu
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, United States, 15213
Contact: Carol Oriss, R.N. 412-383-1434 orissca@upmc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy
Division of Infectious Diseases & HIV Medicine at Drexel University College of Medicine
Philadelphia, Pennsylvania, United States, 19102
Contact: Meghan Metz, MS 267.507.6769 Meghan.Metz@DrexelMed.edu
Principal Investigator: Jeffrey Jacobson, MD
Sponsors and Collaborators:
University of Pennsylvania

global AIDS cure clinical trials

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States, 19104
Contact: Kim Hummel 215-349-5786 kim.hummel@uphs.upenn.edu
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

global AIDS cure clinical trials

Recruiting
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15261
Contact: Gabbie M Diaz, R.N. (301) 435-8019 diazgm@mail.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Rifaximin for Chronic Immune Activation in People With HIV
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Contact: Catherine A Seamon, R.N. (301) 451-6313 cseamon@cc.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov Sponsors and Collaborators
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
University of Pittsburgh Division of Infectious Diseases
Walter Reed Navy MMC

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, United States, 19104
Contact: Joseph Quinn, R.N., B.S.N. 215-349-8093 joseph.quinn@uphs.upenn.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators:
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States, 19104
Contact: Jay R Kostman, MD 215-662-8693 kostman@mail.med.upenn.edu
Contact: Kenneth Lynn, RN 215-662-8217 Kenneth.Lynn@uphs.upenn.edu
Principal Investigator: Jay R Kostman, MD
AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States, 19104
Contact: Pablo Tebas, MD 215-615-4321 pablo.tebas@uphs.upenn.edu
Contact: Kathryn Maffei, RN 215-349-8092 kathryn.maffei@uphs.upenn.edu
Principal Investigator: Pablo Tebas, MD
Sponsors and Collaborators:
University of Pennsylvania
The Wistar Institute
Merck Sharp & Dohme Corp.

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Division of Infectious Disease and HIV Medicine Partnership Comprehensive Care Practice
Philadelphia, Pennsylvania, United States, 191002
Sponsors and Collaborators:
Argos Therapeutics

Rhode Island

Rhode Island

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
The Miriam Hosp. ACTG CRS (2951)
Providence, Rhode Island, United States, 02906
Contact: Pamela Poethke, RN 401-793-4971 ppoethke@lifespan.org Principal Investigator: Karen T. Tashim, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Tennessee

Tennessee

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Vanderbilt Therapeutics (VT) CRS
Nashville, Tennessee, United States, 37204
Contact: Deborah Sutherland, R.N., B.S.N., C.C.R.P. 615-936-8516 deborah.sutherland@vanderbilt.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Vanderbilt Therapeutics (VT) CRS
Nashville, Tennessee, United States, 37204
Contact: Deborah Sutherland, R.N., B.S.N., C.C.R.P. 615-936-8516 deborah.sutherland@vanderbilt.edu Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Texas

Texas

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Houston AIDS Research Team CRS (31473)
Houston, Texas, United States, 77030
Contact: Hilda Cuervo 713-500-6751 Hilda.cuervo@uth.tmc.edu Principal Investigator: Roberto C. Arduino, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Gordon Crofoot, MD, PA
Houston, Texas, United States, 77098
Contact: Charles Sydnor 713-526-0005 charless@crofootmd.com
Principal Investigator: Gordon Crofoot, MD
Sponsors and Collaborators:
Sangamo Biosciences

global AIDS cure clinical trials

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Contact: Uday Popat, MD 713-745-3055 upopat@mdanderson.org

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Texas Transplant Institute
San Antonio, Texas, United States, 78229
Contact: Paul Shaughnessy, MD 210-575-6907 Paul.Shaughnessy@MHShealth.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Gordon Crofoot, MD, PA
Houston, Texas, United States, 77098
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Utah

Utah

Global Cure AIDS Clinical Trials

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Utah
Salt Lake City, Utah, United States, 84132
Contact: Mary Horowitz, MD, MS marymh@mcw.edu
Contact: Ellen Parker eparker@emmes.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Washington

Washington

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
University of Washington AIDS CRS (1401)
Seattle, Washington, United States, 98104
Contact: Christine Jonsson 206-744-8886 cjonsson@uw.edu Principal Investigator: Ann Collier, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

global AIDS cure clinical trials

Recruiting
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109
Contact: Ann E. Woolfrey 206-667-4453
Principal Investigator: Ann E. Woolfrey
Sponsors and Collaborators:
Fred Hutchinson Cancer Research Center
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)

global AIDS cure clinical trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
University of Washington AIDS CRS
Seattle, Washington, United States, 98104-9929
Contact: Christine Jonsson 206-744-8886 cjonsson@u.washington.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109
Contact: Ann E. Woolfrey 206-667-4453
Principal Investigator: Ann E. Woolfrey
Sponsors and Collaborators:
Fred Hutchinson Cancer Research Center
National Cancer Institute (NCI)

Puerto Rico

Puerto Rico

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Clinical Research Puerto Rico
San Juan, Puerto Rico, 00909
Contact: Javier Morales-Ramirez, MD 787-723-5945 crpr@clinicalresearchpr.com
Principal Investigator: Javier Morales-Ramirez, MD
Sponsors and Collaborators:
Sangamo Biosciences

 

Other Countries Global Cure AIDS Clinical Trials

 (Click on a Country below to find Global Cure AIDS Clinical Trials in that area).

Australia

Australia

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
Alfred Hospital
Melbourne, Australia, 3004
Contact: Michelle Hagenauer 61 3 9076 6908 clinresearch@alfred.org.au
Contact: Janine Roney 61 3 9076 2296 j.roney@alfred.org.au
Principal Investigator: Julian Elliott, MD
Sponsors and Collaborators:
University of California, San Francisco
Monash University
amfAR (The Foundation for AIDS Research)
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
Australia, Victoria
The Alfred Hospital – Infectious Diseases Unit
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators:
Bayside Health
Merck Sharp & Dohme Corp.

Belgium

Belgium

Global Cure AIDS Clinical Trials

Ongoing but Not Recruiting
Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
CHU Saint-Pierre
Bruxelles, Belgium, B-1000
CHU Liège
Liège, Belgium, B-4000
Sponsors and Collaborators:
Theravectys S.A.

Canada

Canada

Global Cure AIDS Clinical Trials

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 816
Canada, Quebec
Clinique médicale l’Actuel
Montréal, Quebec, Canada, H2L4P9
Clinique Médical du Quartier Latin
Montréal, Quebec, Canada, H2L5B1
Montreal Chest Institute, Immunodeficiency Dept.
Montréal, Quebec, Canada, H2X 2P4
Sponsors and Collaborators:
Argos Therapeutics

Ongoing but Not Recruiting
Intense Acute Infection Study
University of Toronto
Toronto, Ontario, Canada, M5B 1W8
Maple Leaf Medical Clinic
Toronto, Ontario, Canada, M5G 1K2
Sponsors and Collaborators:
University of Toronto
St. Michael’s Hospital, Toronto
Maple Leaf Medical Clinic

China

China

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS
Beijing Ditan Hospital of Capital Medical University
Beijing, China
Contact: Xingwang Li 15611973658 ditanlxw@yahoo.com.cn
Principal Investigator: Xingwang Li
Sub-Investigator: Rongmeng Jiang
Principal Investigator: Xingwang Li, M.D. Beijng Ditan Hospital of Capital Medical University
Principal Investigator: Rongmeng Jiang, M.D. Beijng Ditan Hospital of Capital Medical University
Principal Investigator: Yi Zeng National Institute for Viral Disease Control and Prevention, China CDC
Principal Investigator: Xia Feng, Ph.D National Institute for Viral Disease Control and Prevention, China CDC
Principal Investigator: Ke Xu, Ph.D National Institute for Viral Disease Control and Prevention, China CDC
Sponsors and Collaborators:
Centers for Disease Control and Prevention, China
Beijing Ditan hospital of Capital Medical University
National Institutes for Food and Drug Control

Denmark

Denmark

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Safety and Efficacy of the Histone Deacetylase Inhibitor Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV‐1 Reservoir (REDUC)
Aarhus University Hospital, Skejby Sygehus
Aarhus N, Denmark, 8200
Contact: Ole Schmeltz Søgaard, MD +45 78 45 28 42 olesoega@rm.dk
Principal Investigator: Lars Østergaard, MD, PhD, DMSc, Professor
Sponsors and Collaborators:
Bionor Immuno AS
Celgene Corporation

France

France

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Lipopeptide Immunisation With GTU-multiHIV Trial
Service d’Immunologie clinique, Centre de vaccination anti-VIH ANRS Mondor Ile-de-France, Hôpital Henri Mondor
Créteil, France, 94010
Contact: Yves Lévy, PU-PH 33 (0) 1 49 81 44 42 yves.levy@hmn.aphp.fr
Contact: Jean-Daniel Lelièvre 33 (0) 1 49 81 44 42 jean-daniel.lelievre@hmn.aphp.fr
Principal Investigator: Jean-Daniel Lelièvre, PU-PH
Sponsors and Collaborators:
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)

global AIDS cure clinical trials

Recruiting
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Hôpital Pitié Salpêtrière
Paris, France, 75013
Contact: Christine Katlama, MD, PhD +33 1 42 16 01 42
Principal Investigator: Christine Katalama, MD, PhD
Hôpital Saint-Antoine
Paris, France, 75012
Contact: Pierre-Marie Girard, Pr +33 (0)1 49 28 24 38
Principal Investigator: Pierre-Marie Girard, Pr
Hôpital Cochin Saint Vincent de Paul
Paris, France, 75014
Contact: Odile Launay, Pr +33 (0)1 58 41 28 58
Principal Investigator: Odile Launay, Pr
Hôpital Tenon
Paris, France, 75020
Contact: Gilles Pialoux, Pr +33 (0)1 56 01 74 12
Principal Investigator: GIlles Pialoux, Pr
Hôpital Pitié Salpêtrière
Paris, France, 75013
Contact: Anne Simon, Dr +33 (0)1 42 16 10 93
Principal Investigator: Anne Simon, Dr
Sponsors and Collaborators:
InnaVirVax

global AIDS cure clinical trials

Recruiting
The ” Extreme ” Cohort (CODEX)
Lambotte
Kremlin Bicetre, France
Contact: Olivier Lambotte, Professor 01 49 59 67 54 olivier.lambotte@bct.aphp.fr
Contact: Faroudy Boufassa 01 45 21 23 65 faroudy.boufassa@inserm.fr
Sponsors and Collaborators:
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)

Not yet Recruiting (Come Back or Contact)
Towards HIV Functional Cure (ULTRASTOP)
University Hospital of Bicêtre
Le Kremlin Bicêtre, France, 94275
Contact: Olivier LAMBOTTE, MD +33145212783 olivier.lambotte@bct.aphp.fr
Contact: Katia BOURDIC +33145216316 katia.bourdic@bct.aphp.fr
Principal Investigator: Olivier LAMBOTTE, MD
Hospital Pitié-Salpêtrière
Paris, France, 75013
Contact: Christine KATLAMA, MD +33142160130 christine.katlama@psl.aphp.fr
Contact: Ruxandra CALIN, MD +33142160129 ruxandra.calin@psl.aphp.fr
Principal Investigator: Christine KATLAMA, MD
Sub-Investigator: Roland TUBIANA, MD
Sub-Investigator: Marc-Antoine VALANTIN, MD
Sub-Investigator: Nadine KTORZA, MD
Sub-Investigator: Luminita SCHNEIDER, MD
Sponsors and Collaborators:
Objectif Recherche Vaccins SIDA
Fondation Bettencourt-Schueller

Not yet recruiting (Come Back or Contact)
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Hôpital de la Croix Rousse
Lyon, France, 69317
Contact: Laurent Cotte, Dr +33 (0)4 72 07 18 99
Principal Investigator: Laurent Cotte, Dr
Hôpital Gui de Chauliac
Montpellier, France, 34295
Contact: Jacques Reynes, Pr +33 (0)4 67 33 72 14
Principal Investigator: Jacques Reynes, Pr
Sponsors and Collaborators:
InnaVirVax

Ongoing but Not Recruiting
Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein (EVATAT)
Centre d’Investigation Clinique – Universitary Hospital Centre Conception
Marseille, France, 13385
Sponsors and Collaborators:
BIOSANTECH
Assistance Publique Hopitaux De Marseille

Ongoing but Not Recruiting
Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
CHU Clermont-Ferrand
Clermont-Ferrand, France, 65003
CHU Dijon
Dijon, France, 21079
CHU Croix-Rousse
Lyon, France, 69317
CIC Cochin-Pasteur; Hôpital Cochin
Paris, France, 75014
Hôpital Saint-Louis
Paris, France, 75010
CHU Rennes
Rennes, France, 35033
Hôpital Nord
Saint-Etienne, France, 42055
CHU Strasbourg
Strasbourg, France, 6091
Hôpital Purpan
Toulouse, France, 31059
CHU Nancy-Brabois
Vandoeuvre-les-Nancy, France, 54511
Sponsors and Collaborators:
Theravectys S.A.

Germany

Germany

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
High-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Contact: Axel R Zander, Prof. Dr. Dr. +49-40-7410-54850 zander@uke.uni-hamburg.de
Contact: Marion Heinzelmann, R. N. +49-40-7410-54188 mheinzel@uke.uni-hamburg.de
Principal Investigator: Axel R Zander, Prof. Dr. Dr.
Sub-Investigator: Jan van Lunzen, PD Dr.
Sub-Investigator: Alex Zoufaly, Dr.
Sponsors and Collaborators:
Universitätsklinikum Hamburg-Eppendorf

Not yet Recruiting (Come Back or Contact)
German Centre for Infection Research HIV Translational Platform
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany, 50931
Contact: Jörg Janne Vehreschild, MD, +49 221 478 86973, janne.vehreschild@ctuc.de
Contact: Gerd Fätkenheuer, MD, +49 221 478 3324. g.faetkenheuer@uni-koeln.de
Sponsors and Collaborators:
University Hospital of Cologne
German Centre for Infection Research (DZIF)
German Federal Ministry of Education and Research (BMBF)

Not yet Recruiting (Come Back or Contact)
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Jürgen Rockstroh
Bonn, Germany, 53105
Contact: Jürgen Rockstroh, Pr +49 (0)228 287 16558
Principal Investigator: Jürgen Rockstroh, Pr
Sponsors and Collaborators:
InnaVirVax

Ongoing but Not Recruiting
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)
EIPMED – Gesellschaft fűr epidemiologische und klinische Forschung in der Medizin mbH Rubensstrasse 125
Berlin, Germany, 12157
Charite Campus, Virchow-Klinikum Medizinische Klinik mit Schwerpunkt Infektiologie Station 59 (Suedring 11) Augustenburger Platz 1 Berlin, Germany, 13353
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Klinik I für Innere Medizin Klinikum Der Universität zu Köln
Köln, Germany, 50937
Contact: Vidar Wendel-Hansen, Dr. med Bionor Pharma ASA, Kronprinsesse Märthas Plass 1, P.O. Box 1477 Vika, NO-0116 Oslo, Norway
Sponsors and Collaborators:
Bionor Immuno AS
Celgene Corporation

Ongoing but Not Recruiting
Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients (GIEU006)
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20249
ICH Grindel
Hamburg, Germany, 20146
ifi-Medizin GmbH at the Asklepios Klinik St. Georg
Hamburg, Germany, 20099
Contact: Jan Van Lunzen, PhD, MD Universitätsklinikum Hamburg-Eppendorf
Sponsors and Collaborators:
Genetic Immunity
Universitätsklinikum Hamburg-Eppendorf
Investigators

Ongoing but Not Recruiting
New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NewEra)
Onkology Karlsruhe
Karlsruhe, Baden-Wuerttemberg, Germany, 76135
Private Practice for Internal Medicine, Hematology and Oncology
Mannheim, Baden-Wuerttemberg, Germany, 68161
Private Practice Drs Ulmer/Frietsch/Mueller
Stuttgart, Baden-Wuerttemberg, Germany, 70197
Practice Dr. med. Lothar Schneider
Fürth, Bavaria, Germany, 90762
MUC Research
Munich, Bavaria, Germany, 80335
University Munich University Hospital, Dept. of Infectious Diseases
Munich, Bavaria, Germany, 80336
Private Practice Drs Pauli/Becker
Munich, Bavaria, Germany, 80331
ICH Study Center
Hamburg, Germany, 20354
Contact: Hans Jaeger, MD MUC Research GmbH
Contact: Johannes Bogner, Prof., MD University Munich, University Hospital, Dept. of Infectious Diseases,
Sponsors and Collaborators:
MUC Research GmbH
Merck Sharp & Dohme Corp.
AbbVie
Pfizer

South Africa

South Africa

Global Cure AIDS Clinical Trials

Ongoing but Not Recruiting
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers (ISS T-003)
Medunsa Clinical Research Unit (MeCRU)
Medunsa, Gaueg, South Africa, 0204
Contact: Barbara BE Ensoli, MD Istituto Superiore Sanita
Sponsors and Collaborators:
Barbara Ensoli, MD
Italian Ministry of Foreign Affairs – General Direction for Cooperation and Development

Spain

Spain

Global Cure AIDS Clinical Trials

Not yet Recruiting(Come Back or Contact)
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Hospital Clinic University of Barcelona
Barcelona, Spain, 08036
Contact: Jose Gatell, Pr +34 (0)93 227 54 30
Principal Investigator: Jose Gatell, Pr
Sponsors and Collaborators:
InnaVirVax
Investigators
Study Director: raphael ho tsong fang, DVM PhD InnaVirVax

Ongoing but Not Recruiting
Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals
Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916
Clinic de Barcelona Hospital
Barcelona, Spain, 08036
Contact: Christian Brander, PhD Institut de Recerca de la Sida IrsiCaixa-HIVACAT
Contact: Beatriz Mothe, MD,PhD Institut de Recerca de la Sida IrsiCaixa-HIVACAT
Contact: Josep Maria Miró, MD,PhD Hospital Clínic i Provincial de Barcelona, HIVACAT
Sponsors and Collaborators:
IrsiCaixa
Fundacio Lluita Contra la SIDA
Hospital Clinic of Barcelona
HIVACAT
University of Oxford

Ongoing but Not Recruiting
Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1
Hospital Universitario Ramon Y Cajal
Madrid, Spain, 28034
Contact: Santiago Moreno Guillen, MD,PhD HOSPITAL UNIVERSITARIO RAMON Y CAJAL. MADRID
Sponsors and Collaborators:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Pfizer

Thailand

Thailand

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Antiretroviral Therapy for Acute HIV Infection (AAHIV)
Thai Red Cross AIDS Research Centre
Bangkok, Thailand, 10330
Contact: Duanghathai Suttichom, BNS 66 2 254 2566 ext 109 duanghathai.s@searchthailand.org
Contact: Praphan Phanuphak, M.D., Ph.D 66 2 253 0996 praphan.p@chula.ac.th
Contact: Duanghathai Suttichom, BNS 66 2 254 2566 ext 109 duanghathai.s@searchthailand.org
Sponsors and Collaborators:
South East Asia Research Collaboration with Hawaii
Thai Red Cross AIDS Research Centre
Pfizer
Gilead Sciences
Merck Sharp & Dohme Corp.

global AIDS cure clinical trials

Recruiting
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Thai Red Cross AIDS Research Centre
Bangkok, Thailand, 10330
Contact: Nittaya Phanuphak, MD 66 2 253 0996 nittaya.p@chula.ac.th
Contact: Duanghathai Suttichom, BNS 662 254 2566 ext 109 duanghathai.s@searchthailand.org
Contact: Jintanat Ananworanich, MD. 662 254 2566 ext 101 JintanatA@afrims.org
Contact: Nittaya Phanuphak, MD. 662 253 0996 nittaya.p@chula.ac.th
Principal Investigator: Jintanat Ananworanich, M.D., Ph.D
Sponsors and Collaborators:
South East Asia Research Collaboration with Hawaii
Armed Forces Research Institute of Medical Sciences, Thailand
Thai Red Cross AIDS Research Centre
Uganda

global AIDS cure clinical trials

Recruiting
Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Rakai Health Sciences Program Uganda Virus Research Institute
Kalisizo, Uganda
Contact: Kevin O Newell (301) 846-5365 newellk@mail.nih.gov
Contact: Thomas C Quinn, M.D. (410) 955-7635 tquinn@jhmi.edu Sponsors and Collaborators
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung, and Blood Institute (NHLBI)

Uganda

Uganda

Global Cure AIDS Clinical Trials

global AIDS cure clinical trials

Recruiting
Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Rakai Health Sciences Program Uganda Virus Research Institute
Kalisizo, Uganda
Contact: Kevin O Newell (301) 846-5365 newellk@mail.nih.gov
Contact: Thomas C Quinn, M.D. (410) 955-7635 tquinn@jhmi.edu Sponsors and Collaborators
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung, and Blood Institute (NHLBI)

United Kingdom

United Kingdom

Global Cure AIDS Clinical Trials

Not yet Recruiting (Come Back or Contact)
Prospective HIV Chemotherapy Cohort Study
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom, SW10 9NH
Contact: Mark Bower 020 8237 5054 m.bower@imperial.ac.uk
Principal Investigator: Mark Bower
Sponsors and Collaborators:
Imperial College London
Imperial College Healthcare NHS Trust

Ongoing but Not Recruiting
Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART
Weatherall Institute of Molecular Medicine
Oxford, Oxons, United Kingdom, OX3 9DS
Oxford Genitourinary Medicine
Oxford, Oxon, United Kingdom, OX3 7LJ
Contact: Tomas Hanke University of Oxford
Contact: Andrew McMichael University of Oxford
Contact: Lucy Dorrell University of Oxford
Sponsors and Collaborators:
University of Oxford
Medical Research Council

 


 

Continuous List Below…

Global Cure AIDS Clinical Trials listed by United States and Countries

 

United States Global Cure AIDS Clinical Trials

 

Alabama

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Alabama Therapeutics CRS (5801)
Birmingham, Alabama, United States, 35294
Contact: Karen Savage, BSN 205-975-7925 kgsavage@uab.edu Principal Investigator: Victoria Johnson, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Alabama CRS
Birmingham, Alabama, United States, 35294
Contact: Karen Savage, R.N., B.S.N. 205-975-7925 kgsavage@uab.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Alabama CRS
Birmingham, Alabama, United States, 35294
Contact: Karen Savage, R.N., B.S.N. 205-975-7925 kgsavage@uab.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
The University of Alabama at Birmingham Alabama Vaccine Research Clinic
Birmingham, Alabama, United States, 35294
Sponsors and Collaborators:
GeoVax, Inc.
AIDS Research Consortium of Atlanta
University of Alabama at Birmingham
AIDS Research Alliance

California

Global Cure AIDS Clinical Trials

Recruiting
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
San Francisco General Hospital
San Francisco, California, United States, 94110
Contact: Hiroyu Hatano, MD 415-476-4082 ext 122 hhatano@php.ucsf.edu Principal Investigator: Hiroyu Hatano, MD
Sponsors and Collaborators:
University of California, San Francisco
amfAR (The Foundation for AIDS Research)

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
UCLA CARE Center CRS (601)
Los Angeles, California, United States, 90035
Contact: Maricela Gonzalez 310-557-3798 mmgonzalez@mednet.ucla.edu Principal Investigator: Judith S. Currier, MD, MSc
UCSD, Avrc Crs (701)
San Diego, California, United States, 92103
Contact: Jill Kunkel 619-543-3094 jkunkel@ucsd.edu Principal Investigator: Constance A. Benson, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
UCLA Care Center
Los Angeles, California, United States, 90035
Contact: Maricela Gonzalez 310-557-3729 mmgonzalez@mednet.ucla.edu Principal Investigator: Ronald Mitsuyasu, MD
Quest Clinical Research
San Francisco, California, United States, 94115
Contact: Grace Gonzaga, LPN 415-353-0212 grace@questclinical.com Principal Investigator: Jacob Lalezari, MD
Orange Coast Medical Group (Please note withdrawn)
Newport Beach, California, United States, 92663
Sponsors and Collaborators:
Sangamo Biosciences

Recruiting
Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection
UCLA CARE Center
Los Angeles, California, United States, 90035
Contact: Maricela Gonzalez 310-557-3729 mmgonzalez@mednet.ucla.edu
Principal Investigator: Ronald Mitsuyasu, M.D.
Quest Clinical Research
San Francisco, California, United States, 94115
Contact: Grace Gonzaga 415-353-0212 grace@questclinical.com
Principal Investigator: Jacob Lalezari, M.D.
Sponsors and Collaborators:
Calimmune, Inc.

Recruiting
Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
City of Hope Medical Center
Duarte, California, United States, 91010
Contact: Amrita Y. Krishnan 626-256-4673 AKrishnan@coh.org
Principal Investigator: Amrita Y. Krishnan
Sponsors and Collaborators:
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
San Francisco General Hospital
San Francisco, California, United States, 94110
Contact: Marian Kerbleski, RN 415-476-4082 ext 144 kerbleskim@php.ucsf.edu
Contact: Rebecca Hoh, MS, RD 415-476-4082 ext 139 rhoh@php.ucsf.edu
Principal Investigator: Steven Deeks, MD
Sponsors and Collaborators:
University of California, San Francisco
Monash University
amfAR (The Foundation for AIDS Research)
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
City of Hope
Duarte, California, United States, 91010
Contact: John Zaia 626-256-4673
Principal Investigator: John Zaia
Sponsors and Collaborators:
Fred Hutchinson Cancer Research Center
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)

Recruiting
The Use of Leukapheresis to Support HIV Pathogenesis Studies
San Francisco General Hospital
San Francisco, California, United States, 94110
Contact: Hiroyu Hatano, MD 415-476-4082 ext 122 hhatano@php.ucsf.edu
Contact: Kara Harvill, BA 415-476-4082 ext 341 harvillk@php.ucsf.edu
Principal Investigator: Hiroyu Hatano, MD
Sponsors and Collaborators:
University of California, San Francisco

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
UCLA CARE Center CRS
Los Angeles, California, United States, 90035
Contact: Arezou S. Akha 310-557-3798 asadighi@mednet.ucla.edu
UCSF HIV/AIDS Crs
San Francisco, California, United States, 94110
Contact: Jay Dwyer 415-476-4082 ext 353 jdwyer@php.ucsf.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
UCSF HIV/AIDS Crs
San Francisco, California, United States, 94110
Contact: Jay Dwyer 415-476-4082 ext 353 jdwyer@php.ucsf.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
City of Hope National Medical Center
Duarte, California, United States, 91010
University of California Los Angeles
Los Angeles, California, United States, 90035
Contact: Mary Horowitz, MD, MS marymh@mcw.edu
Contact: Ellen Parker eparker@emmes.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
UCLA Center for AIDS Research and Education
Los Angeles, California, United States, 90035
Orange Coast Medical Group
Newport Beach, California, United States, 92663
Quest Clinical Research
San Francisco, California, United States, 94115
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma
City of Hope Medical Center
Duarte, California, United States, 91010-3000
Sponsors and Collaborators:
City of Hope Medical Center
National Cancer Institute (NCI)

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
UC Davis Research Office at CARES
Sacramento, California, United States, 95811
Sponsors and Collaborators:
Argos Therapeutics

Ongoing but Not Recruiting
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
AIDS Research Alliance
Los Angeles, California, United States, 90015
Sponsors and Collaborators:
GeoVax, Inc.
AIDS Research Consortium of Atlanta
University of Alabama at Birmingham
AIDS Research Alliance

Colorado

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
University of Colorado Hospital CRS (6101)
Aurora, Colorado, United States, 80045
Contact: Mary G Ray, RN, MSN 303-724-0712 graham.ray@uchsc.edu Principal Investigator: Thomas B Campbell, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
University of Colorado Hospital CRS
Aurora, Colorado, United States, 80045
Contact: Mary Graham Ray, R.N., M.S.N. 303-724-0712 graham.ray@ucdenver.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting(Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
University of Colorado Hospital CRS
Aurora, Colorado, United States, 80045
Contact: Mary Graham Ray, R.N., M.S.N. 303-724-0712 graham.ray@ucdenver.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Connecticut

Global Cure AIDS Clinical Trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Circle CARE Center, LLC
Norwalk, Connecticut, United States, 06850
Contact: Greg Ulrich, RN 203-852-9525 gulrich@whcccc.org
Principal Investigator: Gary Blick, MD
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Circle CARE Center, LLC
Norwalk, Connecticut, United States, 06851
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

District of Columbia (Washington, DC)

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Georgetown University CRS (GU CRS) (1008)
Washington, District of Columbia, United States, 20007
Contact: Abimael Lopez 202-687-7387 al374@georgetown.edu Principal Investigator: Princy N. Kumar, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
CD4-ZETA Gene Modified T Cells With and Without Exogenous Interleukin-2 (IL-2) In HIV Patients
Walter Reed Army Medical Center
Washington, District of Columbia, United States, 20307
Sponsors and Collaborators:
University of Pennsylvania

Florida

Global Cure AIDS Clinical Trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Orlando Immunology Center
Orlando, Florida, United States, 32803
Contact: Jeffrey Garrett, ARNP 407-647-3960 ext 2151 jgarrett@oicorlando.com
Principal Investigator: Edwin DeJesus, MD
Sponsors and Collaborators:
Sangamo Biosciences

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Florida College of Medicine
Gainesville, Florida, United States, 32610-0277
Contact: John R Wingard, MD 352-273-7760 wingajr@medicine.ufl.edu
H. Lee Moffitt Cancer Center
Tampa, Florida, United States, 33624
Contact: Ernesto Ayala, MD 813-745-1554 ernesto.ayala@moffitt.org
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Recruiting
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (GCHT01)
University of Miami School of Medicine, AIDS Clinical Research unit
Miami, Florida, United States, 33136
Contact: Lillian Colon, RN,BSN 305-243-3838 lcolon2@med.miami.edu
Principal Investigator: Margaret A. Fischl, MD
Sponsors and Collaborators:
GeneCure Biotechnologies

Recruiting
Very Early Intensive Treatment of HIV-Infected Infants to Achieve HIV Remission
University of Florida Center for HIV/AIDS Research, Education, and Service
Jacksonville, Florida, United States, 32209
Contact: Anne Coletti, MS 919-544-7040 ext 11238 acoletti@fhi360.org
Principal Investigator: Mobeen Rathore, MD
Sponsors and Collaborators:
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Not yet Recruiting (Come Back or Contact)
Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection (Goldrake)
University of Miami – AIDS Clinical Research Unit
Miami, Florida, United States, 33136
Contact: Margaret Fischl, MD 305-243-3847 mfschl@med.miami.edu Principal Investigator: Margaret Fischl, MD
Sub-Investigator: Hector Bolivar, MD
Sponsors and Collaborators:
Vaccine and Gene Therapy Institute, Florida
University of Miami

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Orlando Immunology Center
Orlando, Florida, United States, 32803
Contact: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Georgia

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
The Ponce de Leon Ctr. CRS (5802)
Atlanta, Georgia, United States, 30308
Contact: Ericka Patrick 404-616-6313 erpatri@emory.edu Principal Investigator: Carlos del Rio, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
AIDS Research Consortium of Atlanta
Atlanta, Georgia, United States, 30312
Sponsors and Collaborators:
GeoVax, Inc.
AIDS Research Consortium of Atlanta
University of Alabama at Birmingham
AIDS Research Alliance

Illinois

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Northwestern University CRS (2701)
Chicago, Illinois, United States, 60611
Contact: Baiba Berzins, MPH 312-695-5012 baiba@northwestern.edu Principal Investigator: Babafemi Taiwo, MBBS, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Maryland

Global Cure AIDS Clinical Trials

Recruiting
VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected…
National Institutes of Health Clinical Center
9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Contact: For additional information, please contact VRC Clinic 301-451-8715 vaccines@nih.gov Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
IHV Baltimore Treatment CRS (4651)
Baltimore, Maryland, United States, 21201
Contact: Gregory Brogden, BS 410-706-1660 gbrogden@ihv.umaryland.edu Principal Investigator: Charles Davis, MD
Beth Israel Deaconess Medical Center ACTG CRS (103)
Boston, Maryland, United States, 02215
Contact: Andrea Kershaw, ANP 617-632-7627 akersha1@bidmc.harvard.edu Principal Investigator: Mary Albrecht, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Therapeutic Vaccine for HIV
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov
Contact: Kathleen R Gittens (301) 496-9320 gittenskr@mail.nih.gov
Contact: Michael C Sneller, M.D. (301) 496-0491 msneller@niaid.nih.gov
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
Profectus Biosciences, Inc.

Recruiting
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
National Institutes of Health Clinical Center
9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov
Contact: Gabbie M Diaz, R.N. (301) 435-8019 diazgm@mail.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Rifaximin for Chronic Immune Activation in People With HIV
Walter Reed National Medical Center
Bethesda, Maryland, United States, 20301
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: Catherine A Seamon, R.N. (301) 451-6313 cseamon@cc.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Johns Hopkins Medical Institutions
Baltimore, Maryland, United States, 21231
Contact: Richard Ambinder, MD 410-955-8839 rambind1@jhmi.edu
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Massachusetts

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
BMC ACTG Crs (104)
Boston, Massachusetts, United States, 02118
Contact: Betsy Adams, RN 617-414-7082 betsy.adams@bmc.org Principal Investigator: Paul Skolnik, MD
Brigham and Women’s Hosp. ACTG CRS (107)
Boston, Massachusetts, United States, 02115
Contact: Jon Gothing, RN 617-732-5635 jgothing@partners.org Principal Investigator: Paul E. Sax, MD
Massachusetts General Hospital ACTG CRS (101)
Boston, Massachusetts, United States, 02114
Contact: Teri Flynn, RN, ANP, MSN 617-724-0072 tflynn@partners.org Principal Investigator: Rajesh Gandhi, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, United States, 02114
Contact: Theresa Flynn, R.N., M.S.N., A.N.P. 617-724-0072 tflynn@partners.org
Brigham and Women’s Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS Not yet recruiting
Boston, Massachusetts, United States, 02115
Contact: Cheryl E. Keenan 617-732-5635 ckeenan2@partners.org
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Massachusetts General Hospital CRS (MGH CRS)
Boston, Massachusetts, United States, 02114
Contact: Theresa Flynn, R.N., M.S.N., A.N.P., B.S.N. 617-724-0072 tflynn@partners.org Brigham and Women’s Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
Boston, Massachusetts, United States, 02115
Contact: Cheryl E. Keenan, R.N. 617-732-5635 ckeenan2@partners.org
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects (PARC002)
Infectious Disease Unit; Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Sponsors and Collaborators:
Massachusetts General Hospital

Minnesota

Global Cure AIDS Clinical Trials

Recruiting
Tissue Drug Levels of HIV Medications
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Contact: Ann Thorkelson, RN 612-625-7472 segu0017@umn.edu
Principal Investigator: Timothy W. Schacker, M.D.
Sponsors and Collaborators:
University of Minnesota – Clinical and Translational Science Institute
National Institute of Allergy and Infectious Diseases (NIAID)

Missouri

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Washington University CRS (2101)
St. Louis, Missouri, United States, 63110
Contact: Michael Klebert, RNC, PhD, ANP 1-314-747-1098 mklebert@im.wustl.edu Principal Investigator: Edgar T. Overton, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Central West Clinical Research, Inc.
St Louis, Missouri, United States, 63108
Contact: Mark Pinson 314-652-0100 ext 832 mark.cwhealth@gmail.com
Principal Investigator: David A Parks, MD
Sponsors and Collaborators:
Sangamo Biosciences

Recruiting
IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
Washington University School of Medicine
St Louis, Missouri, United States
Principal Investigator: Rachel Presti, MD, PhD
Sponsors and Collaborators:
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Washington University Therapeutics (WT) CRS
St. Louis, Missouri, United States, 63110-1010
Contact: Michael K. Klebert, R.N.,C., Ph.D., A.N.P., BCP 314-747-1098 mklebert@dom.wustl.edu Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Central West Clinical Research, Inc.
St Louis, Missouri, United States, 63108
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

New Jersey

Global Cure AIDS Clinical Trials

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601
Contact: Scott Rowley, MD 201-996-5828 srowley@humed.com
Contact: Melissa Baker, MD mbaker@humed.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

New Mexico

Global Cure AIDS Clinical Trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Southwest CARE Center
Santa Fe, New Mexico, United States, 87505
Contact: Jason Martinez 505-216-0318 jmartinez@southwestcare.org
Principal Investigator: Trevor Hawkins, MD
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Southwest CARE Center
Santa Fe, New Mexico, United States, 87505
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

New York

Global Cure AIDS Clinical Trials

Recruiting
A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Monoclonal Antibody in HIV-infected and HIV-uninfected Volunteers
The Rockefeller University
New York, New York, United States, 10065
Contact: Lauren Corregano 800-782-2737 rucares@rockefeller.edu Principal Investigator: Marina Caskey, MD
Sponsors and Collaborators:
Rockefeller University

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Bronx-Lebanon Hosp. Ctr. CRS (31469)
Bronx, New York, United States, 10457
Contact: Megan A Tuohy, MPH 718-901-6346 mtuohy@bronxleb.org Principal Investigator: Edward Telzak, MD
HIV Prevention & Treatment CRS (30329)
New York, New York, United States, 10032
Contact: Steven Chang 212-305-1570 sc1286@columbia.edu Principal Investigator: Scott M. Hammer, MD
Univ. of Rochester ACTG CRS (1101)
Rochester, New York, United States, 14642
Contact: Carol Greisberger, RN, BS 585-275-2740 carol_greisberger@urmc.rochester.edu Principal Investigator: Amneris Luque, MD
AIDS Community Health Ctr. ACTG CRS (1108)
Rochester, New York, United States, 14604
Contact: Carol Greisberger, RN, CCRC 585-275-2740 Carol_Greisberger@urmc.rochester.edu Principal Investigator: Roberto Corales, DO
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Ricky K Hsu, MD, PC
New York, New York, United States, 10011
Contact: Monique Carasso, NP 212-627-7560 mjcarasso@verizon.net
Principal Investigator: Ricky K Hsu, MD, PC
Sponsors and Collaborators:
Sangamo Biosciences

Recruiting
Poly-ICLC in Treated HIV Infection
The Rockefeller University Hospital
New York, New York, United States, 10065
Contact: Elizabeth A Miller, MD 212-824-9246 elizabeth.a.miller@mssm.edu
Principal Investigator: Elizabeth A Miller, MD
Sponsors and Collaborators:
Bhardwaj, Nina, M.D.
The Campbell Foundation
Oncovir, Inc.

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
University of Rochester Adult HIV Therapeutic Strategies Network CRS
Rochester, New York, United States, 14642
Contact: Emily L. Cosimano, B.S.N. 585-276-5903 Emily_Cosimano@urmc.rochester.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University Medical Center
New York, New York, United States, 10032
Contact: Jean Sosna, RN 212-305-2050
Principal Investigator: Diane George, MD
Sponsors and Collaborators:
Diane George, MD

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10174
Contact: Ariel Noya, MD noya@mskcc.org
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Ricky K Hsu, MD, PC
New York, New York, United States, 10011
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Jacobi & North Central Bronx Hospitals
Bronx, New York, United States, 10461
Sponsors and Collaborators:
Argos Therapeutics

North Carolina

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
UNC AIDS Crs (3201)
Chapel Hill, North Carolina, United States, 27516
Contact: Cheryl Marcus, RN, BSN 919-843-8761 cjm@med.unc.edu Principal Investigator: David Wohl, MD
Moses H. Cone Memorial Hospital CRS (3203)
Greensboro, North Carolina, United States, 27401
Contact: Kim Epperson, RN 336-832-7888 kim.epperson@mosecone.com Principal Investigator: Timothy Lane
Regional Center for Infectious Disease, Wendover Medical Center CRS (3203)
Greensboro, North Carolina, United States, 27401
Contact: Kim Epperson, R.N., BSN., CCRC (336) 832-3262
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Chapel Hill CRS
Chapel Hill, North Carolina, United States, 27599
Contact: Susan Pedersen 919-966-6713 spederse@med.unc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27514
Contact: JoAnn Kuruc, MSN, RN 919-966-8533 joann_kuruc@med.unc.edu
Sponsors and Collaborators:
University of North Carolina, Chapel Hill
National Institutes of Health (NIH)
Merck Sharp & Dohme Corp.
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
Contact: JoAnn Kuruc, RN, MSN (919) 966-8533 joann_kuruc@med.unc.edu
Contact: Emily Barrows, RN 919-966-7747 emily_barrows@med.unc.edu
Sponsors and Collaborators:
Cynthia L Gay, MD
Argos Therapeutics
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Chapel Hill CRS
Chapel Hill, North Carolina, United States, 27599
Contact: Susan Pedersen 919-966-6713 spederse@med.unc.edu Greensboro CRS
Greensboro, North Carolina, United States, 27401
Contact: Kim Epperson, R.N., B.S.N., CRC 336-832-3262 kim.epperson@conehealth.com
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
AIDS Clinical Trials Unit
Chapel Hill, North Carolina, United States, 27514
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators:
Argos Therapeutics

Ohio

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
University of Cincinnati CRS (2401)
Cincinnati, Ohio, United States, 45267
Contact: Tammy Mansfield, RN, ACRN 513-584-6040 mansfitl@ucmail.uc.edu Principal Investigator: Judith Feinberg, MD
Case CRS (2501)
Cleveland, Ohio, United States, 44106
Contact: Jane Baum, RN 216-844-2546 baum.jane@clevelandactu.org Principal Investigator: Michael M. Lederman, MD
Metro Health CRS (2503)
Cleveland, Ohio, United States, 44109
Contact: Julie Ziegler 216-778-7847 jziegler@metrohealth.org Principal Investigator: Robert C. Kalayjian, MD
The Ohio State Univ. AIDS CRS (2301)
Columbus, Ohio, United States, 43210
Contact: Todd Lusch, BA 614-293-8112 todd.lusch@osumc.edu Principal Investigator: Susan Koletar, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Case CRS
Cleveland, Ohio, United States, 44106
Contact: Jane Baum, R.N. 216-844-2546 jb@clevelandactu.org
Ohio State University CRS
Columbus, Ohio, United States, 43210
Contact: Kathy Watson, B.S.N. 614-293-5856 kathy.watson@osumc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Cincinnati CRS
Cincinnati, Ohio, United States, 45219
Contact: Tammy Miller, R.N., A.C.R.N. 513-584-8373 tammy.miller@uc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Pennsylvania

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Hosp. of the Univ. of Pennsylvania CRS (6201)
Philadelphia, Pennsylvania, United States, 19104
Contact: Joseph Quinn, RN 215-349-8091 joseph.quinn@uphs.upenn.edu Principal Investigator: Pablo Tebas, MD
Pitt CRS (1001)
Pittsburgh, Pennsylvania, United States, 15213
Contact: Christine A. Tripoli, BSN, RN 412-647-0771 tripolica@upmc.edu Principal Investigator: Sharon A. Riddler, MD, MPH
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, United States, 19104
Contact: Joseph Quinn, R.N. 215-349-8093 joseph.quinn@uphs.upenn.edu
University of Pittsburgh CRS
Pittsburgh, Pennsylvania, United States, 15213
Contact: Carol Oriss, R.N. 412-383-1434 orissca@upmc.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy
Division of Infectious Diseases & HIV Medicine at Drexel University College of Medicine
Philadelphia, Pennsylvania, United States, 19102
Contact: Meghan Metz, MS 267.507.6769 Meghan.Metz@DrexelMed.edu
Principal Investigator: Jeffrey Jacobson, MD
Sponsors and Collaborators:
University of Pennsylvania

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States, 19104
Contact: Kim Hummel 215-349-5786 kim.hummel@uphs.upenn.edu
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Recruiting
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15261
Contact: Gabbie M Diaz, R.N. (301) 435-8019 diazgm@mail.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Rifaximin for Chronic Immune Activation in People With HIV
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Contact: Catherine A Seamon, R.N. (301) 451-6313 cseamon@cc.nih.gov
Contact: Frank Maldarelli, M.D. (301) 435-8019 fmalli@mail.nih.gov Sponsors and Collaborators
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
University of Pittsburgh Division of Infectious Diseases
Walter Reed Navy MMC

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Penn Therapeutics, CRS
Philadelphia, Pennsylvania, United States, 19104
Contact: Joseph Quinn, R.N., B.S.N. 215-349-8093 joseph.quinn@uphs.upenn.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators:
University of Pennsylvania
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting

Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States, 19104
Contact: Jay R Kostman, MD 215-662-8693 kostman@mail.med.upenn.edu
Contact: Kenneth Lynn, RN 215-662-8217 Kenneth.Lynn@uphs.upenn.edu
Principal Investigator: Jay R Kostman, MD
AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States, 19104
Contact: Pablo Tebas, MD 215-615-4321 pablo.tebas@uphs.upenn.edu
Contact: Kathryn Maffei, RN 215-349-8092 kathryn.maffei@uphs.upenn.edu
Principal Investigator: Pablo Tebas, MD
Sponsors and Collaborators:
University of Pennsylvania
The Wistar Institute
Merck Sharp & Dohme Corp.

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Division of Infectious Disease and HIV Medicine Partnership Comprehensive Care Practice
Philadelphia, Pennsylvania, United States, 191002
Sponsors and Collaborators:
Argos Therapeutics

Rhode Island

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
The Miriam Hosp. ACTG CRS (2951)
Providence, Rhode Island, United States, 02906
Contact: Pamela Poethke, RN 401-793-4971 ppoethke@lifespan.org Principal Investigator: Karen T. Tashim, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Tennessee

Global Cure AIDS Clinical Trials

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Vanderbilt Therapeutics (VT) CRS
Nashville, Tennessee, United States, 37204
Contact: Deborah Sutherland, R.N., B.S.N., C.C.R.P. 615-936-8516 deborah.sutherland@vanderbilt.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Vanderbilt Therapeutics (VT) CRS
Nashville, Tennessee, United States, 37204
Contact: Deborah Sutherland, R.N., B.S.N., C.C.R.P. 615-936-8516 deborah.sutherland@vanderbilt.edu Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Texas

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
Houston AIDS Research Team CRS (31473)
Houston, Texas, United States, 77030
Contact: Hilda Cuervo 713-500-6751 Hilda.cuervo@uth.tmc.edu Principal Investigator: Roberto C. Arduino, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Gordon Crofoot, MD, PA
Houston, Texas, United States, 77098
Contact: Charles Sydnor 713-526-0005 charless@crofootmd.com
Principal Investigator: Gordon Crofoot, MD
Sponsors and Collaborators:
Sangamo Biosciences

Recruiting
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Contact: Uday Popat, MD 713-745-3055 upopat@mdanderson.org

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Texas Transplant Institute
San Antonio, Texas, United States, 78229
Contact: Paul Shaughnessy, MD 210-575-6907 Paul.Shaughnessy@MHShealth.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Ongoing but Not Recruiting
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Gordon Crofoot, MD, PA
Houston, Texas, United States, 77098
Study Director: Winson Tang, M.D. Sangamo Biosciences
Sponsors and Collaborators:
Sangamo Biosciences

Utah

Global Cure AIDS Clinical Trials

Not yet Recruiting (Come Back or Contact)
Allogeneic Transplant in HIV Patients (BMT CTN 0903)
University of Utah
Salt Lake City, Utah, United States, 84132
Contact: Mary Horowitz, MD, MS marymh@mcw.edu
Contact: Ellen Parker eparker@emmes.com
Sponsors and Collaborators:
Medical College of Wisconsin
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
Blood and Marrow Transplant Clinical Trials Network

Washington

Global Cure AIDS Clinical Trials

Recruiting
FTC/RPV/TDF on T-Cell Activation, CD4 Cell Count, Inflammatory Biomarkers and Viral Reservoir
University of Washington AIDS CRS (1401)
Seattle, Washington, United States, 98104
Contact: Christine Jonsson 206-744-8886 cjonsson@uw.edu Principal Investigator: Ann Collier, MD
Sponsors and Collaborators:
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109
Contact: Ann E. Woolfrey 206-667-4453
Principal Investigator: Ann E. Woolfrey
Sponsors and Collaborators:
Fred Hutchinson Cancer Research Center
National Institute of Allergy and Infectious Diseases (NIAID)
National Cancer Institute (NCI)

Recruiting
Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
University of Washington AIDS CRS
Seattle, Washington, United States, 98104-9929
Contact: Christine Jonsson 206-744-8886 cjonsson@u.washington.edu
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet Recruiting (Come Back or Contact)
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109
Contact: Ann E. Woolfrey 206-667-4453
Principal Investigator: Ann E. Woolfrey
Sponsors and Collaborators:
Fred Hutchinson Cancer Research Center
National Cancer Institute (NCI)

Puerto Rico

Global Cure AIDS Clinical Trials

Recruiting
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Clinical Research Puerto Rico
San Juan, Puerto Rico, 00909
Contact: Javier Morales-Ramirez, MD 787-723-5945 crpr@clinicalresearchpr.com
Principal Investigator: Javier Morales-Ramirez, MD
Sponsors and Collaborators:
Sangamo Biosciences
_____________________________________________________________________________________________

Other Countries Global AIDS Cure Clinical Trials

Australia

Global Cure AIDS Clinical Trials

Recruiting
Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
Alfred Hospital
Melbourne, Australia, 3004
Contact: Michelle Hagenauer 61 3 9076 6908 clinresearch@alfred.org.au
Contact: Janine Roney 61 3 9076 2296 j.roney@alfred.org.au
Principal Investigator: Julian Elliott, MD
Sponsors and Collaborators:
University of California, San Francisco
Monash University
amfAR (The Foundation for AIDS Research)
National Institute of Allergy and Infectious Diseases (NIAID)

Ongoing but Not Recruiting
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
Australia, Victoria
The Alfred Hospital – Infectious Diseases Unit
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators:
Bayside Health
Merck Sharp & Dohme Corp.

Belgium

Global Cure AIDS Clinical Trials

Ongoing but Not Recruiting
Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
CHU Saint-Pierre
Bruxelles, Belgium, B-1000
CHU Liège
Liège, Belgium, B-4000
Sponsors and Collaborators:
Theravectys S.A.

Canada

Global Cure AIDS Clinical Trials

Ongoing but Not Recruiting
Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 816
Canada, Quebec
Clinique médicale l’Actuel
Montréal, Quebec, Canada, H2L4P9
Clinique Médical du Quartier Latin
Montréal, Quebec, Canada, H2L5B1
Montreal Chest Institute, Immunodeficiency Dept.
Montréal, Quebec, Canada, H2X 2P4
Sponsors and Collaborators:
Argos Therapeutics

Ongoing but Not Recruiting
Intense Acute Infection Study
University of Toronto
Toronto, Ontario, Canada, M5B 1W8
Maple Leaf Medical Clinic
Toronto, Ontario, Canada, M5G 1K2
Sponsors and Collaborators:
University of Toronto
St. Michael’s Hospital, Toronto
Maple Leaf Medical Clinic

China

Global Cure AIDS Clinical Trials

Recruiting
Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS
Beijing Ditan Hospital of Capital Medical University
Beijing, China
Contact: Xingwang Li 15611973658 ditanlxw@yahoo.com.cn
Principal Investigator: Xingwang Li
Sub-Investigator: Rongmeng Jiang
Principal Investigator: Xingwang Li, M.D. Beijng Ditan Hospital of Capital Medical University
Principal Investigator: Rongmeng Jiang, M.D. Beijng Ditan Hospital of Capital Medical University
Principal Investigator: Yi Zeng National Institute for Viral Disease Control and Prevention, China CDC
Principal Investigator: Xia Feng, Ph.D National Institute for Viral Disease Control and Prevention, China CDC
Principal Investigator: Ke Xu, Ph.D National Institute for Viral Disease Control and Prevention, China CDC
Sponsors and Collaborators:
Centers for Disease Control and Prevention, China
Beijing Ditan hospital of Capital Medical University
National Institutes for Food and Drug Control

Denmark

Global Cure AIDS Clinical Trials

Recruiting
Safety and Efficacy of the Histone Deacetylase Inhibitor Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV‐1 Reservoir (REDUC)
Aarhus University Hospital, Skejby Sygehus
Aarhus N, Denmark, 8200
Contact: Ole Schmeltz Søgaard, MD +45 78 45 28 42 olesoega@rm.dk
Principal Investigator: Lars Østergaard, MD, PhD, DMSc, Professor
Sponsors and Collaborators:
Bionor Immuno AS
Celgene Corporation

France

Global Cure AIDS Clinical Trials

Recruiting
Lipopeptide Immunisation With GTU-multiHIV Trial
Service d’Immunologie clinique, Centre de vaccination anti-VIH ANRS Mondor Ile-de-France, Hôpital Henri Mondor
Créteil, France, 94010
Contact: Yves Lévy, PU-PH 33 (0) 1 49 81 44 42 yves.levy@hmn.aphp.fr
Contact: Jean-Daniel Lelièvre 33 (0) 1 49 81 44 42 jean-daniel.lelievre@hmn.aphp.fr
Principal Investigator: Jean-Daniel Lelièvre, PU-PH
Sponsors and Collaborators:
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)

Recruiting
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Hôpital Pitié Salpêtrière
Paris, France, 75013
Contact: Christine Katlama, MD, PhD +33 1 42 16 01 42
Principal Investigator: Christine Katalama, MD, PhD
Hôpital Saint-Antoine
Paris, France, 75012
Contact: Pierre-Marie Girard, Pr +33 (0)1 49 28 24 38
Principal Investigator: Pierre-Marie Girard, Pr
Hôpital Cochin Saint Vincent de Paul
Paris, France, 75014
Contact: Odile Launay, Pr +33 (0)1 58 41 28 58
Principal Investigator: Odile Launay, Pr
Hôpital Tenon
Paris, France, 75020
Contact: Gilles Pialoux, Pr +33 (0)1 56 01 74 12
Principal Investigator: GIlles Pialoux, Pr
Hôpital Pitié Salpêtrière
Paris, France, 75013
Contact: Anne Simon, Dr +33 (0)1 42 16 10 93
Principal Investigator: Anne Simon, Dr
Sponsors and Collaborators:
InnaVirVax

Recruiting
The ” Extreme ” Cohort (CODEX)
Lambotte
Kremlin Bicetre, France
Contact: Olivier Lambotte, Professor 01 49 59 67 54 olivier.lambotte@bct.aphp.fr
Contact: Faroudy Boufassa 01 45 21 23 65 faroudy.boufassa@inserm.fr
Sponsors and Collaborators:
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)

Not yet Recruiting (Come Back or Contact)
Towards HIV Functional Cure (ULTRASTOP)
University Hospital of Bicêtre
Le Kremlin Bicêtre, France, 94275
Contact: Olivier LAMBOTTE, MD +33145212783 olivier.lambotte@bct.aphp.fr
Contact: Katia BOURDIC +33145216316 katia.bourdic@bct.aphp.fr
Principal Investigator: Olivier LAMBOTTE, MD
Hospital Pitié-Salpêtrière
Paris, France, 75013
Contact: Christine KATLAMA, MD +33142160130 christine.katlama@psl.aphp.fr
Contact: Ruxandra CALIN, MD +33142160129 ruxandra.calin@psl.aphp.fr
Principal Investigator: Christine KATLAMA, MD
Sub-Investigator: Roland TUBIANA, MD
Sub-Investigator: Marc-Antoine VALANTIN, MD
Sub-Investigator: Nadine KTORZA, MD
Sub-Investigator: Luminita SCHNEIDER, MD
Sponsors and Collaborators:
Objectif Recherche Vaccins SIDA
Fondation Bettencourt-Schueller

Not yet recruiting (Come Back or Contact)
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Hôpital de la Croix Rousse
Lyon, France, 69317
Contact: Laurent Cotte, Dr +33 (0)4 72 07 18 99
Principal Investigator: Laurent Cotte, Dr
Hôpital Gui de Chauliac
Montpellier, France, 34295
Contact: Jacques Reynes, Pr +33 (0)4 67 33 72 14
Principal Investigator: Jacques Reynes, Pr
Sponsors and Collaborators:
InnaVirVax

Ongoing but Not Recruiting
Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein (EVATAT)
Centre d’Investigation Clinique – Universitary Hospital Centre Conception
Marseille, France, 13385
Sponsors and Collaborators:
BIOSANTECH
Assistance Publique Hopitaux De Marseille

Ongoing but Not Recruiting
Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
CHU Clermont-Ferrand
Clermont-Ferrand, France, 65003
CHU Dijon
Dijon, France, 21079
CHU Croix-Rousse
Lyon, France, 69317
CIC Cochin-Pasteur; Hôpital Cochin
Paris, France, 75014
Hôpital Saint-Louis
Paris, France, 75010
CHU Rennes
Rennes, France, 35033
Hôpital Nord
Saint-Etienne, France, 42055
CHU Strasbourg
Strasbourg, France, 6091
Hôpital Purpan
Toulouse, France, 31059
CHU Nancy-Brabois
Vandoeuvre-les-Nancy, France, 54511
Sponsors and Collaborators:
Theravectys S.A.

Germany

Global Cure AIDS Clinical Trials

Recruiting
High-Dose Chemotherapy With Transplantation of Gene-Modified Stem Cells for High-Risk AIDS-Related Lymphoma
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Contact: Axel R Zander, Prof. Dr. Dr. +49-40-7410-54850 zander@uke.uni-hamburg.de
Contact: Marion Heinzelmann, R. N. +49-40-7410-54188 mheinzel@uke.uni-hamburg.de
Principal Investigator: Axel R Zander, Prof. Dr. Dr.
Sub-Investigator: Jan van Lunzen, PD Dr.
Sub-Investigator: Alex Zoufaly, Dr.
Sponsors and Collaborators:
Universitätsklinikum Hamburg-Eppendorf

Not yet Recruiting (Come Back or Contact)
German Centre for Infection Research HIV Translational Platform
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany, 50931
Contact: Jörg Janne Vehreschild, MD, +49 221 478 86973, janne.vehreschild@ctuc.de
Contact: Gerd Fätkenheuer, MD, +49 221 478 3324. g.faetkenheuer@uni-koeln.de
Sponsors and Collaborators:
University Hospital of Cologne
German Centre for Infection Research (DZIF)
German Federal Ministry of Education and Research (BMBF)

Not yet Recruiting (Come Back or Contact)
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Jürgen Rockstroh
Bonn, Germany, 53105
Contact: Jürgen Rockstroh, Pr +49 (0)228 287 16558
Principal Investigator: Jürgen Rockstroh, Pr
Sponsors and Collaborators:
InnaVirVax

Ongoing but Not Recruiting
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART) (IMID)
EIPMED – Gesellschaft fűr epidemiologische und klinische Forschung in der Medizin mbH Rubensstrasse 125
Berlin, Germany, 12157
Charite Campus, Virchow-Klinikum Medizinische Klinik mit Schwerpunkt Infektiologie Station 59 (Suedring 11) Augustenburger Platz 1 Berlin, Germany, 13353
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246
Klinik I für Innere Medizin Klinikum Der Universität zu Köln
Köln, Germany, 50937
Contact: Vidar Wendel-Hansen, Dr. med Bionor Pharma ASA, Kronprinsesse Märthas Plass 1, P.O. Box 1477 Vika, NO-0116 Oslo, Norway
Sponsors and Collaborators:
Bionor Immuno AS
Celgene Corporation

Ongoing but Not Recruiting
Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients (GIEU006)
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20249
ICH Grindel
Hamburg, Germany, 20146
ifi-Medizin GmbH at the Asklepios Klinik St. Georg
Hamburg, Germany, 20099
Contact: Jan Van Lunzen, PhD, MD Universitätsklinikum Hamburg-Eppendorf
Sponsors and Collaborators:
Genetic Immunity
Universitätsklinikum Hamburg-Eppendorf
Investigators

Ongoing but Not Recruiting
New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients (NewEra)
Onkology Karlsruhe
Karlsruhe, Baden-Wuerttemberg, Germany, 76135
Private Practice for Internal Medicine, Hematology and Oncology
Mannheim, Baden-Wuerttemberg, Germany, 68161
Private Practice Drs Ulmer/Frietsch/Mueller
Stuttgart, Baden-Wuerttemberg, Germany, 70197
Practice Dr. med. Lothar Schneider
Fürth, Bavaria, Germany, 90762
MUC Research
Munich, Bavaria, Germany, 80335
University Munich University Hospital, Dept. of Infectious Diseases
Munich, Bavaria, Germany, 80336
Private Practice Drs Pauli/Becker
Munich, Bavaria, Germany, 80331
ICH Study Center
Hamburg, Germany, 20354
Contact: Hans Jaeger, MD MUC Research GmbH
Contact: Johannes Bogner, Prof., MD University Munich, University Hospital, Dept. of Infectious Diseases,
Sponsors and Collaborators:
MUC Research GmbH
Merck Sharp & Dohme Corp.
AbbVie
Pfizer

South Africa

Global Cure AIDS Clinical Trials

Ongoing but Not Recruiting
A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers (ISS T-003)
Medunsa Clinical Research Unit (MeCRU)
Medunsa, Gaueg, South Africa, 0204
Contact: Barbara BE Ensoli, MD Istituto Superiore Sanita
Sponsors and Collaborators:
Barbara Ensoli, MD
Italian Ministry of Foreign Affairs – General Direction for Cooperation and Development

Spain

Global Cure AIDS Clinical Trials

Not yet Recruiting(Come Back or Contact)
Assessment of the Therapeutic Properties of the VAC-3S Immunoprotective Vaccine When Combined With Standard ART in the Course of HIV-1 Infection
Hospital Clinic University of Barcelona
Barcelona, Spain, 08036
Contact: Jose Gatell, Pr +34 (0)93 227 54 30
Principal Investigator: Jose Gatell, Pr
Sponsors and Collaborators:
InnaVirVax
Investigators
Study Director: raphael ho tsong fang, DVM PhD InnaVirVax

Ongoing but Not Recruiting
Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals
Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916
Clinic de Barcelona Hospital
Barcelona, Spain, 08036
Contact: Christian Brander, PhD Institut de Recerca de la Sida IrsiCaixa-HIVACAT
Contact: Beatriz Mothe, MD,PhD Institut de Recerca de la Sida IrsiCaixa-HIVACAT
Contact: Josep Maria Miró, MD,PhD Hospital Clínic i Provincial de Barcelona, HIVACAT
Sponsors and Collaborators:
IrsiCaixa
Fundacio Lluita Contra la SIDA
Hospital Clinic of Barcelona
HIVACAT
University of Oxford

Ongoing but Not Recruiting
Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1
Hospital Universitario Ramon Y Cajal
Madrid, Spain, 28034
Contact: Santiago Moreno Guillen, MD,PhD HOSPITAL UNIVERSITARIO RAMON Y CAJAL. MADRID
Sponsors and Collaborators:
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Pfizer

Thailand

Global Cure AIDS Clinical Trials

Recruiting
Antiretroviral Therapy for Acute HIV Infection (AAHIV)
Thai Red Cross AIDS Research Centre
Bangkok, Thailand, 10330
Contact: Duanghathai Suttichom, BNS 66 2 254 2566 ext 109 duanghathai.s@searchthailand.org
Contact: Praphan Phanuphak, M.D., Ph.D 66 2 253 0996 praphan.p@chula.ac.th
Contact: Duanghathai Suttichom, BNS 66 2 254 2566 ext 109 duanghathai.s@searchthailand.org
Sponsors and Collaborators:
South East Asia Research Collaboration with Hawaii
Thai Red Cross AIDS Research Centre
Pfizer
Gilead Sciences
Merck Sharp & Dohme Corp.

Recruiting
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
Thai Red Cross AIDS Research Centre
Bangkok, Thailand, 10330
Contact: Nittaya Phanuphak, MD 66 2 253 0996 nittaya.p@chula.ac.th
Contact: Duanghathai Suttichom, BNS 662 254 2566 ext 109 duanghathai.s@searchthailand.org
Contact: Jintanat Ananworanich, MD. 662 254 2566 ext 101 JintanatA@afrims.org
Contact: Nittaya Phanuphak, MD. 662 253 0996 nittaya.p@chula.ac.th
Principal Investigator: Jintanat Ananworanich, M.D., Ph.D
Sponsors and Collaborators:
South East Asia Research Collaboration with Hawaii
Armed Forces Research Institute of Medical Sciences, Thailand
Thai Red Cross AIDS Research Centre

Uganda

Global Cure AIDS Clinical Trials

Recruiting
Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Rakai Health Sciences Program Uganda Virus Research Institute
Kalisizo, Uganda
Contact: Kevin O Newell (301) 846-5365 newellk@mail.nih.gov
Contact: Thomas C Quinn, M.D. (410) 955-7635 tquinn@jhmi.edu Sponsors and Collaborators
Sponsors and Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Heart, Lung, and Blood Institute (NHLBI)

United Kingdom

Global Cure AIDS Clinical Trials

Not yet Recruiting (Come Back or Contact)
Prospective HIV Chemotherapy Cohort Study
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom, SW10 9NH
Contact: Mark Bower 020 8237 5054 m.bower@imperial.ac.uk
Principal Investigator: Mark Bower
Sponsors and Collaborators:
Imperial College London
Imperial College Healthcare NHS Trust

Ongoing but Not Recruiting
Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART
Weatherall Institute of Molecular Medicine
Oxford, Oxons, United Kingdom, OX3 9DS
Oxford Genitourinary Medicine
Oxford, Oxon, United Kingdom, OX3 7LJ
Contact: Tomas Hanke University of Oxford
Contact: Andrew McMichael University of Oxford
Contact: Lucy Dorrell University of Oxford
Sponsors and Collaborators:
University of Oxford
Medical Research Council

 

_____________________________________________________________________________________________

Upcoming

Global Cure AIDS Clinical Trials

ACTG A5321: Decay of HIV-1 reservoirs in subjects on long-term antiretroviral therapy: The ACTG HIV reservoirs cohort (AHRC) study
Check ACTG website for more information here.